Forbright, Inc. has drawn a sudden wave of short-selling interest since its mid-September listing, even as the borrow market remains wide open and the analyst community is broadly constructive.
The most striking development this week is in the short book. Short interest has more than tripled over the past week — up 163% — and has risen roughly 258% from a month ago, climbing from around 37,000 shares in mid-August to nearly 134,000 by September 25. In absolute terms the position is still modest, and without a confirmed free-float figure the percentage of float cannot be precisely calculated. But the directional move is sharp, and the pace of accumulation is notable for a newly public name. This looks less like a structural short thesis and more like early-days price discovery by traders testing a fresh ticker.
The borrow market tells a more nuanced story. Cost to borrow is elevated at 25.2% — up roughly 24% from a month ago, though it has eased back from a recent peak near 32% in mid-September. Despite that elevated rate, availability remains extremely loose: roughly 3.7 million shares are available to borrow, representing an availability ratio of 873%. That means shorts face no supply constraint whatsoever. The high cost appears to reflect the newness of the stock in the lending market rather than any genuine squeeze dynamic — there is no shortage of shares to borrow, just a premium for being first to establish the position.
The Street came out of the gate broadly positive when coverage launched in early July. Goldman Sachs initiated with a Buy and a $23.50 target, Barclays matched with Overweight and $23, and TD Cowen added a Buy. The more cautious voices — JP Morgan and Piper Sandler — both initiated Neutral. Since then, Wells Fargo raised its target from $21 to $22 in August after the Q2 print, while JP Morgan nudged its own target from $21 to $23. The analyst consensus mean price target runs near $22.92, implying roughly 30% upside to the September 25 close of $17.67. The stock trades at 9.1x trailing earnings and 0.82x book — the kind of valuation that leaves room for re-rating if credit quality holds. The price-to-book multiple has drifted about 4% lower over the past 30 days, tracking the stock's 4.5% monthly decline.
The ownership picture reflects the freshness of the listing. The register is dominated by a handful of large pre-IPO holders: Gallatin Point Capital and Centerbridge Partners together control more than 40% of shares. Bayview Asset Management built a 10.7% stake, and Wellington Management disclosed a fresh 9% passive position in a Schedule 13G filed August 13. John Delaney and GPC Partners each disclosed stakes above 13% and 9% respectively in separate 13G filings around the same date. All five filers are on the 13G register — passive, not activist intent. As the standard disclosure caveat applies: these positions are as-last-disclosed around the 5% threshold, and any holder dropping below that level may not file again. The concentration of pre-IPO holders means any rotation out of these large blocks would materially reshape the float.
Forbright reports its next quarter on October 30. The two prior prints produced muted same-day moves — roughly +0.8% and -1.6% respectively — though both saw further drift lower over the following week. The October print will be the first earnings event where meaningful public short interest and a broader institutional register are in place, making the setup around that date the clearest near-term focal point for this stock.
See the live data behind this article on ORTEX.
Open FRBT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
